Aflibercept 2 mg for Neovascular Age-Related Macular Degeneration: XTEND at 3 Years
{{output}}
Introduction: Long-term, global, data evaluating intravitreal aflibercept (IVT-AFL) 2 mg for treatment of neovascular age-related macular degeneration (nAMD) in real-world practice are needed. This study investigated the long-ter... ...